Enhanced stability and activity of an antimicrobial peptide in conjugation with silver nanoparticle

Journal of Colloid and Interface Science

Volumn 483, Issue , 2016, Pages 385-393

  Pal, Indrani ^a   Brahmkhatri, Varsha P ^a   Bera, Swapna ^b   Bhattacharyya, Dipita ^b   Quirishi, Yasrib ^a   Bhunia, Anirban ^b   Atreya, Hanudatta S ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b BOSE INSTITUTE   (India)

Author keywords

Antimicrobial peptide; Fast chemical exchange; Membrane interaction; NMR spectroscopy; Peptide nanoparticle conjugate; Silver nanoparticle

Indexed keywords

AMINO ACIDS; BIOACTIVITY; DRUG INTERACTIONS; METAL NANOPARTICLES; MICROORGANISMS; NANOPARTICLES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; POLYPEPTIDES;

ANTIMICROBIAL PEPTIDE; CHEMICAL EXCHANGE; MEMBRANE INTERACTIONS; NANOPARTICLE CONJUGATE; SILVER NANOPARTICLES;

SILVER;

ODORRANAIN A OA 1; POLYPEPTIDE ANTIBIOTIC AGENT; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; 1-PALMITOYL-2-OLEOYLGLYCERO-3-PHOSPHOGLYCEROL; 1-PALMITOYL-2-OLEOYLPHOSPHATIDYLETHANOLAMINE; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BIOMIMETIC MATERIAL; CYSTEINE; LIPOSOME; METAL NANOPARTICLE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; SILVER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; CONTROLLED STUDY; DRUG CONFORMATION; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG STABILITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IC50; KERATINOCYTE; MEMBRANE BINDING; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL; AMINO ACID SEQUENCE; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL VIABILITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOMIMETIC MATERIALS; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CYSTEINE; DRUG STABILITY; ESCHERICHIA COLI; HUMANS; KERATINOCYTES; MAGNETIC RESONANCE SPECTROSCOPY; METAL NANOPARTICLES; MICROBIAL VIABILITY; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLGLYCEROLS; SILVER; UNILAMELLAR LIPOSOMES;

EID: 84989892658     PISSN: 00219797     EISSN: 10957103     Source Type: Journal    
DOI: 10.1016/j.jcis.2016.08.043     Document Type: Article

References (38)

1. [1] Zasloff, M., Antimicrobial peptides of multicellular organisms. Nature 415 (2002), 389–395.
2. [2] Levy, S.B., Marshall, B., Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10 (2004), S122–S129.
3. [3] Datta, A., Ghosh, A., Airoldi, C., Sperandeo, P., Mroue, K.H., Jiménez-Barbero, J., Kundu, P., Ramamoorthy, A., Bhunia, A., Antimicrobial peptides: insights into membrane permeabilization, lipopolysaccharide fragmentation and application in plant disease control. Sci. Rep. 5 (2015), 1–15.
4. [4] Brogden, K.A., Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 3 (2005), 238–250.
5. [5] Chernousova, S., Epple, M., Silver as antibacterial agent: Ion, nanoparticle, and metal. Angew. Chem. - Int. Ed. 52 (2013), 1636–1653.
6. [6] Bao, H., Yu, X., Xu, C., Li, X., Li, Z., Wei, D., Liu, Y., New toxicity mechanism of silver nanoparticles: promoting apoptosis and inhibiting proliferation. PLoS One 10 (2015), 1–10.
7. [7] Liu, L., Yang, J., Xie, J., Luo, Z., Jiang, J., Yang, Y.Y., Liu, S., The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for gram-positive bacteria over erythrocytes. Nanoscale 5 (2013), 3834–3840.
8. [8] Ruden, S., Hilpert, K., Berditsch, M., Wadhwani, P., Ulrich, A.S., Synergistic interaction between silver nanoparticles and membrane-permeabilizing antimicrobial peptides. Antimicrob. Agents Chemother. 53 (2009), 3538–3540.
9. [9] Brahmkhatri, V.P., Chandra, K., Dubey, A., Atreya, H.S., An ultrastable conjugate of silver nanoparticles and protein formed through weak interactions. Nanoscale 7 (2015), 12921–12931.
10. [10] Ceccon, A., Tugarinov, V., Bax, A., Clore, G.M., Global dynamics and exchange kinetics of a protein on the surface of nanoparticles revealed by relaxation-based solution NMR spectroscopy. J. Am. Chem. Soc. 138 (2016), 5789–5792.
11. [11] Thorndyke, M., Peptides in invertebrates. Comp. Physiol. Regul. Pept., 1989, 203–228.
12. [12] Poblete, H., Agarwal, A., Thomas, S.S., Bohne, C., Ravichandran, R., Phospase, J., Comer, J., Alarcon, E.I., New insights into peptide-silver nanoparticle interaction: deciphering the role of cysteine and lysine in the peptide sequence. Langmuir 32 (2015), 265–273.
13. [13] Yang, X., Lee, W.H., Zhang, Y., Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. J. Proteome Res. 11 (2012), 306–319.
14. [14] Hartmann, M., Berditsch, M., Hawecker, J., Ardakani, M.F., Gerthsen, D., Ulrich, A.S., Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrob. Agents Chemother. 54 (2010), 3132–3142.
15. [15] Benincasa, M., Pacor, S., Gennaro, R., Scocchi, M., Rapid and reliable detection of antimicrobial peptide penetration into gram-negative bacteria based on fluorescence quenching. Antimicrob. Agents Chemother. 53 (2009), 3501–3504.
16. [16] Thennarasu, S., Lee, D.K., Poon, A., Kawulka, K.E., Vederas, J.C., Ramamoorthy, A., Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A. Chem. Phys. Lipids 137 (2005), 38–51.
17. [17] Agnihotri, S., Mukherji, S., Mukherji, S., Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy. RSC Adv. 4 (2014), 3974–3983.
18. [18] Papadimitriou, K., Pratsinis, H., Nebe-von-caron, G., Kletsas, D., Tsakalidou, E., Rapid assessment of the physiological status of Streptococcus macedonicus by flow cytometry and fluorescence probes. Int. J. Food. Microbiol. 111 (2006), 197–205.
19. [19] Qurishi, Y., Hamid, A., Majeed, R., Hussain, A., Qazi, A.K., Ahmed, M., Zargar, M.A., Singh, S.K., Saxena, A.K., Interaction of natural products with cell survival and signaling pathways in the biochemical elucidation of drug targets in cancer. Future Oncol. 7 (2011), 1007–1021.
20. [20] Wüthrich, K., NMR of Proteins and Nucleic Acids. 1986, Wiley, 10.1039/b618334b.
21. [21] Paramelle, D., Sadovoy, A., Gorelik, S., Free, P., Hobley, J., Fernig, D.G., A rapid method to estimate the concentration of citrate capped silver nanoparticles from UV-visible light spectra. Analyst 139 (2014), 4855–4861.
22. [22] Cavanagh, J., Fairbrother, W.J., Palmer, A.G. III, Skelton, N.J., Protein NMR Spectroscopy, Principles and Practice. 1995, Elsevier Inc.
23. [23] Atreya, H.S., Sahu, S.C., Chary, K.V.R., Govil, G., A tracked approach for automated NMR assignments in proteins (TATAPRO). J. Biomol. NMR 17 (2000), 125–136.
24. [24] Park, S.-H., Kim, H.-E., Kim, C.-M., Yun, H.-J., Choi, E.-C., Lee, B.-J., Role of proline, cysteine and a disulphide bridge in the structure and activity of the anti-microbial peptide gaegurin 5. Biochem. J. 368 (2002), 171–182.
25. [25] Bain, A.D., Chemical exchange in NMR. Prog. Nucl. Magn. Reson. Spectrosc. 43 (2003), 63–103.
26. [26] Williamson, M.P., Using chemical shift perturbation to characterise ligand binding. Prog. Nucl. Magn. Reson. Spectrosc. 73 (2013), 1–16.
27. [27] Franci, G., Falanga, A., Galdiero, S., Palomba, L., Rai, M., Morelli, G., Galdiero, M., Silver nanoparticles as potential antibacterial agents. Molecules 20 (2015), 8856–8874.
28. [28] Ghosh, A., Kar, R.K., Jana, J., Saha, A., Jana, B., Krishnamoorthy, J., Kumar, D., Ghosh, S., Chatterjee, S., Bhunia, A., Indolicidin targets duplex DNA: structural and mechanistic insight through a combination of spectroscopy and microscopy. ChemMedChem 9 (2014), 2052–2058.
29. [29] Fjell, C.D., Hiss, J.A., Hancock, R.E.W., Schneider, G., Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11 (2012), 37–51.
30. [30] Mcdermott, A.M., NIH Public Access 30 (2006), 505–515.
31. [31] Golubeva, O.Y., Shamova, O.V., Orlov, D.S., Pazina, T.Y., Boldina, A.S., Drozdova, I.A., Kokryakov, V.N., Synthesis and study of antimicrobial activity of bioconjugates of silver nanoparticles and endogenous antibiotics. Glas. Phys. Chem. 37 (2011), 78–84.
32. [32] Mohanty, S., Jena, P., Mehta, R., Pati, R., Banerjee, B., Patil, S., Sonawane, A., Cationic antimicrobial peptides and biogenic silver nanoparticles kill mycobacteria without eliciting DNA damage and cytotoxicity in mouse macrophages. Antimicrob. Agents Chemother. 57 (2013), 3688–3698.
33. [33] Liu, L., Xu, K., Wang, H., Tan, P.K.J., Fan, W., Venkatraman, S.S., Li, L., Yang, Y.-Y., Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat. Nanotechnol. 4 (2009), 457–463.
34. [34] Roshmi, T., Soumya, K.R., Jyothis, M., Radhakrishnan, E.K., Effect of biofabricated gold nanoparticle-based antibiotic conjugates on minimum inhibitory concentration of bacterial isolates of clinical origin. Gold Bull., 2015, 63–71.
35. [35] Mohanty, S., Jena, P., Mehta, R., Pati, R., Banerjee, B., Patil, S., Sonawane, A., Cationic antimicrobial peptides and biogenic silver nanoparticles kill mycobacteria without eliciting DNA damage and cytotoxicity in mouse macrophages. Antimicrob. Agents Chemother. 57 (2013), 3688–3698.
36. [36] Sherlina Daphny, C., Arputha Bibiana, M., Vengatesan, R., Selvamani, P., Latha, S., Antimicrobial peptides-A milestone for developing antibiotics against drug resistant infectious pathogens. J. Pharm. Sci. Res. 7 (2015), 226–230.
37. [37] Zhao, J., Zhao, C., Liang, G., Zhang, M., Zheng, J., Engineering antimicrobial peptides with improved antimicrobial and hemolytic activities. J. Chem. Inf. Model. 53 (2013), 3280–3296.
38. [38] Zhang, T., Wang, L., Chen, Q., Chen, C., Cytotoxic potential of silver nanoparticles. Yonsei Med. J. 55 (2014), 283–291.